Please use this identifier to cite or link to this item: https://scholarhub.balamand.edu.lb/handle/uob/4218
DC FieldValueLanguage
dc.contributor.advisorDaher, Jalilen_US
dc.contributor.authorSamad, Ghadir AbdelLatif Elen_US
dc.date.accessioned2020-12-23T14:41:07Z-
dc.date.available2020-12-23T14:41:07Z-
dc.date.issued2018-
dc.identifier.urihttps://scholarhub.balamand.edu.lb/handle/uob/4218-
dc.descriptionIncludes bibliographical references (p. 49-71).en_US
dc.description.abstractAtherosclerosis is a critical disease with multiple etiologies and causal factors; early observations have correlated fibrin deposition with atheroma plaque formation. This led to the proposition that a decrease in fibrinolysis in endothelial cells may negatively influence atherogenesis. Endothelial cells themselves maintain a stringent, dynamic and continuous equilibrium by secreting major fibrinolysis and coagulation factors. Since it has been previously confirmed that myeloperoxidase modified low density lipoprotein (MoxLDL) decreases endothelial cell profibrinolytic capacity in real-time without delineating the mechanisms by which this modified LDL can alter pericellular fibrinolysis, we tried in the present study to perform a preliminary dissection of the molecules that might be involved in decreasing fibrinolysis after MoxLDL treatment. Therefore, the initial aim of our study was to assess the effect of MoxLDL by comparing its impact on two different primary cultures of endothelial cells: bovine aortic endothelial (BAE) cells and human aortic endothelial cells (HAEC). We showed that treating BAE cells with a physiological concentration (100 μg/ml) of MoxLDL induced around 70% cell death as determined by propidium iodide staining followed by flow cytometry analysis. On the other hand, HAEC exposed to a physiological concentration of MoxLDL (100 μg/ml) maintained high viability and did not exhibit any significant variation in ROS production as measured by flow cytometry. Most importantly, qRT-PCR results did not show any effect of MoxLDL on the expression level of major fibrinolytic factors: tPA and uPA, the receptor tPAR, and the inhibitors PAI-1 and α2 macroglobulin. These data suggest that the interference of MoxLDL with pericellular fibrinolysis may be due to physical disruptions at the cell surface and not due to changes in gene expression.en_US
dc.description.statementofresponsibilityby Ghadir AbdelLatif El Samaden_US
dc.format.extentx, 71 p. : ill.en_US
dc.language.isoengen_US
dc.rightsThis object is protected by copyright, and is made available here for research and educational purposes. Permission to reuse, publish, or reproduce the object beyond the personal and educational use exceptions must be obtained from the copyright holderen_US
dc.subject.lcshEndotheliumen_US
dc.subject.lcshDissertations, Academicen_US
dc.subject.lcshUniversity of Balamand--Dissertationsen_US
dc.titleEffect of myeloperoxidase modified LDL on bovine and human aortic endothelial cellsen_US
dc.typeThesisen_US
dc.contributor.corporateUniversity of Balamanden_US
dc.contributor.departmentDepartment of Biologyen_US
dc.contributor.facultyFaculty of Arts and Sciencesen_US
dc.contributor.institutionUniversity of Balamanden_US
dc.description.degreeMSc in Biologyen_US
dc.description.statusPublisheden_US
dc.identifier.ezproxyURLhttp://ezsecureaccess.balamand.edu.lb/login?url=http://olib.balamand.edu.lb/projects_and_theses/180165.pdfen_US
dc.identifier.OlibID180165-
dc.relation.ispartofbookseriesUniversity of Balamand. Thesisen_US
dc.provenance.recordsourceOliben_US
Appears in Collections:UOB Theses and Projects
Show simple item record

Record view(s)

3
checked on Nov 30, 2021

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.